Other Issues: Previous Next
International Journal of Hematology and Oncology 2024, Vol 34, Num 4

Ebru KILIC GUNES, Tuba BULDUK, Burak DUMLUDAG, Haydar ZENGIN, Murat YILDIRIM, Melda COMERT, Meltem AYLI Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients.UHOD , 2024 , 34 , 175-183
Abstract | PDF | Mail to Author | Mail to Editor |


Veysel GOK, Firdevs AYDIN, Alper OZCAN, Zehra Filiz KARAMAN, Ebru YILMAZ, Orhan GORUKMEZ, Ozlem GORUKMEZ, Atil BISGIN, Musa KARAKUKCU, Turkan PATIROGLU, Ekrem UNAL The Effect of Nivolumab in Pediatric Malignant Tumors: A Single Center Experience with Nine Children.UHOD , 2024 , 34 , 184-194
Abstract | PDF | Mail to Author | Mail to Editor |


Ivo GOKMEN, Nazan DEMIR, Pinar PEKER, Erkan OZCAN, Fahri AKGUL, Ismail BAYRAKCI, Didem DIVRIKLIOGLU, Muhammet Bekir HACIOGLU, Bulent ERDOGAN, Sernaz TOPALOGLU Comparison of Breast Graded Prognostic Assessment Scores in a Turkish Cohort of Patients with Brain Metastatic Breast Cancer.UHOD , 2024 , 34 , 195-205
Abstract | PDF | Mail to Author | Mail to Editor |


Nargiz MAJIDOVA, Sedat YILDIRIM, Erkam KOCAASLAN, Ali Kaan GUREN, Hacer Sahika YILDIZ, Muhammed Fatih KIRCALI, Mustafa SEYYAR, Nadiye SEVER, Nedim TURAN, Ibrahim Vedat BAYOGLU Gustave Roussy Immune Score (GRIm-Score) Predicts Prognosis in Non-Small Cell Lung Cancer Patients Undergoing Nivolumab: A Multicenter Retrospective Study from Turkiye.UHOD , 2024 , 34 , 206-212
Abstract | PDF | Mail to Author | Mail to Editor |


Nadiye SEVER, Sedat YILDIRIM, Hacer Sahika YILDIZ, Sermin DINC SONUSEN, Abdussamet CELEBI, Nargiz MAJIDOVA, Alper YASAR, Erkam KOCAASLAN, Pinar EREL, Yesim AGYOL, Ali Kaan GUREN, Selver ISIK, Ozlem ERCELEP, Rukiye ARIKAN, Ibrahim Vedat BAYOGLU, Murat SARI, Osman KOSTEK Long-Term Survival and Disease-Free Rates in Locoregional Anal Squamous Cell Carcinoma: An Institutional Experience.UHOD , 2024 , 34 , 213-219
Abstract | PDF | Mail to Author | Mail to Editor |


Mahmut UCAR, Mukaddes YILMAZ, Eda ERDIS, Birsen YUCEL Comparison of Clinicopathological Features and Survival Outcomes Associated with HER2-Zero and HER2-Low Breast Cancers: A retrospective, Observational Study.UHOD , 2024 , 34 , 220-230
Abstract | PDF | Mail to Author | Mail to Editor |